AmeriPath Credit Set To Hit Market

  • 23 Feb 2003
Email a colleague
Request a PDF

Credit Suisse First Boston and Deutsche Bank are launching this Wednesday a $365 million deal backing plans by Amy Acquisition Corp.-- a Welsh, Carson, Anderson & Stowe company-- to acquire cancer diagnostics provider AmeriPath. The bank duo will be shopping a $290 million "B" piece at LIBOR plus 33/4% and a $75 million revolver. Pricing on the revolver could not be ascertained. The transaction is valued at $839.4 million, including AmeriPath's 2002 debt and an estimated $65.1 million in assumed contingent obligations (LMW, 12/16). CSFB and Deutsche Bank bankers did not return calls.

Riviera Beach, Fla.-based AmeriPath will release its 2002 fourth quarter and year-end financial results tomorrow. There were reports that results fell below investor expectations. James New, ceo of AmeriPath, further acknowledged in a company report that the fourth quarter results were below company targets. He noted, however, that AmeriPath's "cash collections in the fourth quarter and for the year were [still] strong." Welsh Carson and the company expect the transaction to close before April 30 of this year. An AmeriPath spokeswoman did not return calls, while a Welsh Carson official declined to comment.

  • 23 Feb 2003

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 Bank of America Merrill Lynch (BAML) 1,284 2 30.09
2 Barclays 633 1 14.82
3 BNP Paribas 509 1 11.91
4 Citi 467 1 10.94
5 Morgan Stanley 455 1 10.66

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 10,727.09 36 12.76%
2 Barclays 8,051.97 24 9.58%
3 Bank of America Merrill Lynch 7,814.11 25 9.30%
4 JPMorgan 7,477.76 27 8.90%
5 Wells Fargo Securities 6,648.29 26 7.91%